Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Metab Brain Dis ; 39(4): 589-609, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38351421

ABSTRACT

This study aimed to investigate the action of two different formulations of curcumin (Cur)-loaded nanocapsules (Nc) (Eudragit [EUD] and poly (ɛ-caprolactone) [PCL]) in an amnesia mice model. We also investigated the formulations' effects on scopolamine-induced (SCO) depressive- and anxiety-like comorbidities, the cholinergic system, oxidative parameters, and inflammatory markers. Male Swiss mice were randomly divided into five groups (n = 8): group I (control), group II (Cur PCL Nc 10 mg/kg), group III (Cur EUD Nc 10 mg/kg), group IV (free Cur 10 mg/kg), and group V (SCO). Treatments with Nc or Cur (free) were performed daily or on alternate days. After 30 min of treatment, the animals received the SCO and were subjected to behavioral tests 30 min later (Barnes maze, open-field, object recognition, elevated plus maze, tail suspension tests, and step-down inhibitory avoidance tasks). The animals were then euthanized and tissue was removed for biochemical assays. Our results demonstrated that Cur treatment (Nc or free) protected against SCO-induced amnesia and depressive-like behavior. The ex vivo assays revealed lower acetylcholinesterase (AChE) and catalase (CAT) activity, reduced thiobarbituric species (TBARS), reactive species (RS), and non-protein thiols (NSPH) levels, and reduced interleukin-6 (IL-6) and tumor necrosis factor (TNF) expression. The treatments did not change hepatic markers in the plasma of mice. After treatments on alternate days, Cur Nc had a more significant effect than the free Cur protocol, implying that Cur may have prolonged action in Nc. This finding supports the concept that it is possible to achieve beneficial effects in nanoformulations, and treatment on alternate days differs from the free Cur protocol regarding anti-amnesic effects in mice.


Subject(s)
Amnesia , Curcumin , Disease Models, Animal , Nanocapsules , Animals , Curcumin/pharmacology , Curcumin/administration & dosage , Curcumin/therapeutic use , Mice , Male , Amnesia/drug therapy , Amnesia/chemically induced , Oxidative Stress/drug effects , Scopolamine
2.
Microb Pathog ; 158: 104975, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34022358

ABSTRACT

In early December 2019, an outbreak of coronavirus disease 2019 caused by a new strain of coronavirus (SARS-CoV-2), occurred in the city of Wuhan, Hubei Province, China. On January 30, 2020, the World Health Organization (WHO) declared the outbreak a public health emergency of international concern. Since then, frontline healthcare professionals have been experiencing extremely stressful situations and damage to their physical and mental health. These adverse conditions cause stress and biochemical, hematological, and inflammatory changes, as well as oxidative damage, and could be potentially detrimental to the health of the individual. The study population consisted of frontline health professionals working in BHU in a city in southern Brazil. Among the 45 participants, two were infected with the SARS-CoV-2 virus and were diagnosed using immunochromatographic tests such as salivary RT-LAMP and qRT-PCR. We also evaluated biochemical, hematological, inflammatory, and oxidative stress markers in the participants. The infected professionals (CoV-2-Prof) showed a significant increase in the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), cholesterol, lactic dehydrogenase, lymphocytes, and monocytes. In this group, the levels of uric acid, triglycerides, leukocytes, neutrophils, hemoglobin, hematocrit, and platelets decreased. In the group of uninfected professionals (NoCoV-2-Prof), significant increase in HDL levels and the percentages of eosinophils and monocytes, was observed. Further, in this group, uric acid, LDH, triglyceride, and cholesterol levels, and the hematocrit count and mean corpuscular volume were significantly reduced. Both groups showed significant inflammatory activity with changes in the levels of C-reactive protein and mucoprotein. The NoCoV-2-Prof group showed significantly elevated plasma cortisol levels. To our kowledge, this study is the first to report the use of the RT-LAMP method with the saliva samples of health professionals, to evalute of SARS-CoV-2.


Subject(s)
COVID-19 , SARS-CoV-2 , Delivery of Health Care , Humans , Molecular Diagnostic Techniques , Nucleic Acid Amplification Techniques , Oxidative Stress
3.
J Environ Sci Health B ; 55(8): 749-755, 2020.
Article in English | MEDLINE | ID: mdl-32558613

ABSTRACT

This study assessed the hematological, enzymatic and osmoregulatory responses of silver catfish (Rhamdia quelen) exposed to sublethal concentrations (1.125 and 3.750 µg/L) of a commercial thiamethoxam-containing insecticide used on rice crops. Groups of 6 fish per tank (in triplicate, n = 3, total 54 fish) were exposed for up to 96 h to different concentrations of the compound. After this period, fish were placed in clean water for 48 h. Two fish from each tank (6 per treatment) that had been exposed to the insecticide for 24 h were anesthetized with eugenol and blood was collected to evaluate hematological and biochemical parameters. Blood, liver and muscle were collected for determination of metabolic parameters, plasma cortisol, Cl-, Na+ and K+ levels and H+-ATPase and Na+/K+-ATPase activity in the gill. H+-ATPase activity was higher in fish exposed to 1.125 µg/L insecticide at 24 h compared to control (0.0 µg/L). Differences in cortisol levels were evidenced throughout the experimental period. These results indicated that exposure to the insecticide changed the hematological, biochemical and metabolic profile of the animals, suggesting concern about environmental safety. Therefore, we discourage the use of this pesticide in areas that come into contact with water bodies inhabited by fish.


Subject(s)
Catfishes/physiology , Insecticides/toxicity , Thiamethoxam/toxicity , Adenosine Triphosphatases/metabolism , Animals , Catfishes/blood , Ecotoxicology/methods , Gills/drug effects , Gills/metabolism , Hydrocortisone/blood , Liver/drug effects , Muscles/drug effects , Muscles/metabolism , Potassium/metabolism , Sodium/metabolism , Toxicity Tests, Acute , Water Pollutants, Chemical/toxicity
4.
Microb Pathog ; 130: 178-185, 2019 May.
Article in English | MEDLINE | ID: mdl-30862561

ABSTRACT

Pseudomonas aeruginosa is a ubiquitous microorganism that commonly causes hospital-acquired infections, including pneumonia, bloodstream and urinary tract infections and it is well known for chronically colonising the respiratory tract of patients with cystic fibrosis, causing severe intermittent exacerbation of the condition. P. aeruginosa may appear in the free form cell but also grows in biofilm communities adhered to a surface. An alternative to conventional antimicrobial agents are nanoparticles that can act as carriers for antibiotics and other drugs. In this context, the study aimed to characterise and verify the anti-biofilm potential of GML Nanocapsules against P. aeruginosa. The nanocapsules showed a mean diameter of 190.7 nm, polydispersion index of 0.069, the zeta potential of -23.3 mV. The microdilution test showed a MIC of 62.5 µg/mL to GML and 15.62 µg/mL to GML Nanocapsules. The anti-biofilm experiments demonstrated the significant reduction of biomass, proteins, polysaccharide and viable P. aeruginosa in biofilm treated with GML Nanocapsules while the free GML did not cause an effect. The AFM images showed a decrease in a biofilm which received GML. The positive results suggest an alternative for the public health trouble related to infections associated with biofilm.


Subject(s)
Anti-Bacterial Agents/pharmacology , Biofilms/drug effects , Laurates/pharmacology , Monoglycerides/pharmacology , Nanocapsules , Pseudomonas aeruginosa/drug effects , Surface-Active Agents/pharmacology , Drug Carriers , Microbial Sensitivity Tests
5.
Microb Pathog ; 127: 220-224, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30529428

ABSTRACT

The aim of this study was to evaluate the resistance of Rhamdia quelen (silver catfish) to Aeromonas hydrophila infection after treatment with pure and nanoencapsulated forms either terpinen-4-ol, thymol, or carvacrol and the effects of these treatments on fish metabolic responses. After A. hydrophila inoculation, fish were treated with 30 min daily baths for 6 consecutive days with terpinen-4-ol, thymol, or carvacrol in their pure or nanoencapsulated forms at concentrations of 5, 10, 15 or 25 mg L-1. A positive control group, negative control group and saline group were also included. Survival was evaluated at the end of treatment for six consecutive days. Muscle and liver were collected to determine glucose and lactate levels. The fish treated with the nanoencapsulated form of the compounds had a high survival rate, similar to saline group and negative control groups. The carvacrol, thymol and terpinen-4-ol nanoencapsulated forms improved survival of silver catfish infected with A. hydrophila. Muscle and liver glucose and lactate levels are not indicated as biomarkers because they did not present any correlation between the metabolic state of the fish and the bacterial infection.


Subject(s)
Aeromonas hydrophila/growth & development , Anti-Infective Agents/administration & dosage , Fish Diseases/drug therapy , Glucose/analysis , Gram-Negative Bacterial Infections/veterinary , Lactic Acid/analysis , Animals , Catfishes , Cymenes , Fish Diseases/microbiology , Fish Diseases/pathology , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/pathology , Liver/pathology , Monoterpenes/administration & dosage , Muscles/pathology , Survival Analysis , Terpenes/administration & dosage , Thymol/administration & dosage , Treatment Outcome
6.
Mol Biol Rep ; 46(6): 5897-5908, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31410688

ABSTRACT

Phenylketonuria (PKU) is a metabolic disorder accumulating phenylalanine (Phe) and its metabolites in plasma and tissues of the patients. Regardless of the mechanisms, which Phe causes brain impairment, are poorly understood, energy deficit may have linked to the neurotoxicity in PKU. It is widely recognized that creatine is involved in maintaining of cerebral energy homeostasis. Because of this, in a previous work, we incorporated it into liposomes and this increased the concentration of creatine in the cerebral cortex. Here, we examined the effect of creatine nanoliposomes on parameters of oxidative stress, enzymes of phosphoryl transfer network, and activities of the mitochondrial respiratory chain complexes (RCC) in the cerebral cortex of young rats chemically induced hyperphenylalaninemia (HPA). HPA was induced with L-phenylalanine (5.2 µmol/g body weight; twice a day; s.c.), and phenylalanine hydroxylase inhibitor, α-methylphenylalanine (2.4 µmol/g body weight; once a day; i.p.), from the 7th to the 19th day of life. HPA reduced the activities of pyruvate kinase, creatine kinase, and complex II + III of RCC in the cerebral cortex. Creatine nanoliposomes prevented the inhibition of the activities of the complexes II + III, caused by HPA, and changes oxidative profile in the cerebral cortex. Considering the importance of the mitochondrial respiratory chain for brain energy production, our results suggesting that these nanoparticles protect against neurotoxicity caused by HPA, and can be viable candidates for treating patients HPA.


Subject(s)
Creatine/metabolism , Liposomes/metabolism , Phenylketonurias/metabolism , Animals , Brain/metabolism , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Creatine/physiology , Creatine Kinase/metabolism , Energy Metabolism , Female , Hippocampus/metabolism , Male , Nanoparticles/therapeutic use , Oxidation-Reduction , Oxidative Stress/drug effects , Phenylalanine/metabolism , Rats , Rats, Wistar
7.
Microb Pathog ; 124: 116-121, 2018 Nov.
Article in English | MEDLINE | ID: mdl-30138756

ABSTRACT

This study evaluated the antibacterial activity of Origanum majorana essential oil (EOM) and nanocapsules of this oil (NOM) in silver catfish, Rhamdia quelen, infected with Aeromonas hydrophila, and addressed their effects on silver catfish hematological and metabolic parameters. Fish were inoculated with A. hydrophila (360 µL, at a concentration of 1.5 × 109 CFU mL-1) and submitted to 1 h daily baths with EOM (0 (control), 20 or 30 µL L-1), NOM (0 (control), 5 or 10 µL L-1) or a positive control containing florfenicol (30 µL L-1) called group Maxflor® for five consecutive days. All treatments improved the survival rate of the infected fish, but we suggest the treatment of A. hydrophila infections through daily baths with 20 µL L-1 EOM or 5 µL L-1 NOM for five consecutive days as these were the lowest effective concentrations tested. Silver catfish treated with EOM and NOM had higher lymphocyte levels, indicating stimulation of the immune system in these fish. The lowest liver glucose level was found in the group treated with the lowest concentration of NOM, and the lactate values in the liver and muscle of all groups were within the normal values reported for this species. In addition, nanocapsules required much less EOM to elicit effective antibacterial treatment.


Subject(s)
Aeromonas hydrophila/drug effects , Catfishes , Fish Diseases/drug therapy , Gram-Negative Bacterial Infections/veterinary , Immunologic Factors/administration & dosage , Oils, Volatile/administration & dosage , Origanum/chemistry , Animals , Gram-Negative Bacterial Infections/drug therapy , Gram-Negative Bacterial Infections/microbiology , Immunologic Factors/isolation & purification , Oils, Volatile/isolation & purification , Survival Analysis , Treatment Outcome
8.
Microb Pathog ; 110: 694-702, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28159662

ABSTRACT

Pelargonium graveolens is a member of the Geraniaceae family and has been used in folk medicine in many countries because of its anti-inflammatory activity. No studies have yet been reported to evaluate the anti-inflammatory activity of a nanoemulsion containing geranium oil (GO) model in macrophages. In this study the anti-inflammatory effect of Geranium nanoemulsion (NEG) macrophages induced with soluble proteins of Candida albicans was investigated. GO presented citronellol (17.74%) and geraniol (14.43%) as main constituents. The characterization in NEG was demonstrated, showing the particle size of 164 ± 3.5 nm, PDI of 0.12 ± 0.006 and zeta potential -10 mV ± 1.7. The MIC obtained for NEG and GO were 3.64 µg ml-1 and 1.82 µg ml-1, respectively. The viability of the macrophages treated with NEG and GO concentrations (1/2 x, 1x and 2x MIC) was evaluated. There was a significant reduction of viability and the MTT assay was not confirmed after the LDH assay. Anti-inflammatory activity was evaluated by determining nitric oxide (NO), cytokines (interleukin IL-1, IL-6 and IL-10), tumor necrosis factor-α (TNF) and the expression levels gene of interleukin (IL-2), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS). The apoptosis inhibition capacity was assessed by determination of INFγ, caspase 3 and caspase 8. The results indicated that there was a significant increase of NO in the levels after treatment with NEG and significantly reduced levels after treatment with GO. The cytokines (IL-1, IL-6, IL-10, and TNF) were evaluated and NEG (½ x, 1x MIC) decreased IL-1 levels by 1.25-1.37 times, respectively. The NEG did not decrease IL-6 levels and a significant increase was observed for IL-10. GO significantly decreased IL-6 and IL-10 levels. There was a significant decrease in IL-2 and COX-2 levels and increased levels of iNOs. The levels of IFNγ and caspase-3 after treatment with NEG decreased indicating an anti-inflammatory effect and can inhibit apoptosis. Finally, the levels of caspase-8 do not change. Thus, pretreatment with NEG induced an anti-inflammatory effect against soluble proteins of C. albicans model macrophages.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antigens, Fungal/immunology , Candida albicans/chemistry , Macrophages/drug effects , Macrophages/immunology , Oils, Volatile/pharmacology , Pelargonium/chemistry , Acyclic Monoterpenes , Animals , Anti-Inflammatory Agents/isolation & purification , Antigens, Fungal/isolation & purification , Cell Survival/drug effects , Cytokines/metabolism , Emulsions/pharmacology , Macrophages/physiology , Mice , Monoterpenes/analysis , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/metabolism , Oils, Volatile/chemistry , Oils, Volatile/isolation & purification , Prostaglandin-Endoperoxide Synthases/metabolism , RAW 264.7 Cells , Terpenes/analysis
9.
Microb Pathog ; 112: 230-242, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28970174

ABSTRACT

Candida species are the main responsible microorganisms for causing fungal infections worldwide, and Candida albicans is most frequently associated with infectious processes. Pseudomonas aeruginosa is a gram-negative bacterium commonly found in immunocompromised patients. The infection persistence caused by these microorganisms is often related to antimicrobial resistance and biofilm formation. In this context, the objective of the present study was to prepare and characterize nanoemulsions containing Eucalyptus globulus oil and to verify its antimicrobial and antibiofilm activities against P. aeruginosa and Candida spp. The nanoemulsions had a size of approximately 76 nm, a polydispersity index of 0.22, a zeta potential of - 9,42 mV and a pH of approximately 5.0. The E. globulus oil was characterized by gas chromatography, being possible to observe its main components, such as 1-8-Cineol (75.8%), p- Cymene (7.5%), α-Pinene (7.4%) and Limonene (6.4%). The antimicrobial activity of the nanoemulsion was determined from the macrodilution tests and the cell viability curve, where the minimum fungicidal concentration of 0.7 mg/mL for C. albicans and 1.4 mg/mL for C. tropicalis and C. glabrata were obtained. However, the nanoemulsions did not present antimicrobial activity against P. aeruginosa, since it contains only 5% of the oil, being ineffective for this microorganism. The nanoencapsulated oil action against the formed biofilm was evaluated by atomic force microscopy and calcofluor staining, and the nanoemulsion was more efficient for two of the three Candida species when compared to free oil.


Subject(s)
Anti-Infective Agents/pharmacology , Biofilms/drug effects , Candida/drug effects , Eucalyptus/chemistry , Nanoparticles/chemistry , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Pseudomonas aeruginosa/drug effects , Anti-Infective Agents/chemistry , Benzenesulfonates , Bicyclic Monoterpenes , Biofilms/growth & development , Cyclohexanols , Cyclohexenes , Cymenes , Eucalyptol , Hydrogen-Ion Concentration , Limonene , Microbial Sensitivity Tests , Microbial Viability/drug effects , Monoterpenes , Nanotechnology , Oils, Volatile/administration & dosage , Particle Size , Surface Properties , Terpenes
10.
Microb Pathog ; 104: 190-195, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28126664

ABSTRACT

Carya illinoensis is a widespread species, belonging to the Juglandaceae family, commonly known as Pecan. Popularly, the leaves have been used in the treatment of smoking as a hypoglycemic, cleansing, astringent, keratolytic, antioxidant, and antimicrobial agent. The following research aimed to identify for the first time the phytochemical compounds present in the leaves of C. illinoensis and carry out the determination of antimicrobial activity of aqueous and ethanolic extracts. The antimicrobial activity was tested against 20 microorganisms by determining the minimum inhibitory concentration (MIC). Phenolic acids (gallic acid and ellagic acid), flavonoids (rutin), and tannins (catechins and epicatechins) were identified by HPLC-DAD and may be partially responsible for the antimicrobial activity against Gram-positive, Gram-negative, and yeast. The results showed MIC values between 25 mg/mL and 0.78 mg/mL. The extracts were also able to inhibit the production of germ tubes by Candida albicans.


Subject(s)
Antifungal Agents/analysis , Antifungal Agents/pharmacology , Bacteria/drug effects , Carya/chemistry , Phytochemicals/analysis , Phytochemicals/pharmacology , Yeasts/drug effects , Antifungal Agents/isolation & purification , Chromatography, High Pressure Liquid , Flavonoids/analysis , Flavonoids/isolation & purification , Flavonoids/pharmacology , Hydroxybenzoates/analysis , Hydroxybenzoates/isolation & purification , Hydroxybenzoates/pharmacology , Microbial Sensitivity Tests , Phytochemicals/isolation & purification , Plant Leaves/chemistry , Tannins/analysis , Tannins/isolation & purification , Tannins/pharmacology
11.
Microb Pathog ; 113: 432-437, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29162482

ABSTRACT

Microbial biofilms represent a challenge in the treatment of infections, due to the low efficacy of the antimicrobials. This study evaluated the antimicrobial effect of nanoparticles of Melaleuca alternifolia (TTO) in dental biofilm. Thirty-eight volunteers used an oral device in situ in situ including four bovine enamel specimens for 07 days. From the fifth day four solutions were applied randomly for each specimen: Physiological Saline Solution (0.85% NaCl) (C+), Chlorhexidine 0.12% (CHX), M. alternifolia oil 0.3% (TTO), and a nanoparticle solution of 0.3% M. alternifolia oil (NPTTO). The nanoparticles of TTO were characterized for pH, IPD, medium size, zeta potential and Transmission Electron Microscopy. Antimicrobial activity was evaluated by viable microorganisms count and the structure of the biofilm by atomic force microscopy. The NPTTO presented pH 6.4, particle diameter of 197.9 ± 1 nm, polydispersion index of 0.242 ± 0.005, zeta potential of -7.12 mV and ±0:27 spherical shape. The C+ resulted in 100% of bacterial vitality, while CHX, TTO and NPTTO showed 34.2%, 51.4% and 25.8%, respectively. The AFM images showed biofilms with an average roughness of 350 nm for C+, 275 nm for CHX, 500 nm for TTO and 100 nm for NPTTO. The NPTTO demonstrated excellent antimicrobial activity in the biofilm formed in situ and will possibly be used in future for the treatment/prevention of oral biofilms.


Subject(s)
Anti-Infective Agents/pharmacology , Biofilms/drug effects , Melaleuca/chemistry , Nanoparticles/chemistry , Plant Exudates/pharmacology , Adult , Animals , Bacteria/drug effects , Bacterial Adhesion/drug effects , Brazil , Cattle , Chlorhexidine/pharmacology , Colony Count, Microbial , Dental Enamel/microbiology , Dental Plaque/drug therapy , Dental Plaque/microbiology , Dental Plaque/prevention & control , Female , Humans , Hydrogen-Ion Concentration , Male , Microbial Sensitivity Tests , Microbial Viability/drug effects , Particle Size , Pilot Projects , Sodium Chloride/pharmacology , Tea Tree Oil/pharmacology , Time Factors , Young Adult
12.
Microb Pathog ; 111: 6-13, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28804018

ABSTRACT

Bacterial biofilms are involved in various medical infections and for this reason it is of great importance understanding adhesion mechanisms of involved microorganisms is essential to develop new strategies of prevention and control. Different approaches have been used for preventing biofilm related infections in health care settings, such as use of surface coatings agents in medical implants. In this context, is necessary to explore new compounds with anti-biofilm activity. Thus, this study evaluated for the first time the action of A22 against biofilms of Pseudomonas aeruginosa PAO1 strain and multi-resistant clinical isolates on biotic and abiotic surfaces. A22 acts as inhibitor of the MreB protein of the bacterial cell wall, causing the rods to change shape to the coccoid form. In this work, A22 at subinhibitory concentrations was able to prevent biofilm formation, and atomic force microscopy images showed that A22 was highly effective in inhibiting adhesion on polyethylene surfaces. Pseudomonas aeruginosa PAO1 exhibited a strong ability to adhere to HeLa cells, and A22 inhibited the aggregation after 4 h of exposure. Swarming and twitching motilities were significantly altered by A22 at subinhibitory concentrations. Thus, by changing the shape of the bacterial cell, many properties can be affected, such as motility, surface adhesion and biofilm formation. This work presents A22 as a promising novel antibacterial or surface coating agent of medical materials.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Adhesion/drug effects , Biofilms/drug effects , Cell Movement/drug effects , Pseudomonas aeruginosa/drug effects , Thiourea/analogs & derivatives , Bacterial Proteins/drug effects , Biofilms/growth & development , Cell Wall , HeLa Cells , Humans , Microbial Sensitivity Tests , Microscopy, Atomic Force , Polyethylene , Thiourea/antagonists & inhibitors , Time Factors
13.
Ecotoxicol Environ Saf ; 139: 73-77, 2017 May.
Article in English | MEDLINE | ID: mdl-28110048

ABSTRACT

Glycerol Monolaurate (GML) is a compound with known antimicrobial potential, however it is not much used due to its low solubility in water and high melting point. The nanoencapsulation of some drugs offers several advantages such as improved stability and solubility in water. The present study aimed to produce, characterize, and evaluate the ecotoxicity of GML nanocapsules. The nanocapsules were produced and presented a mean diameter of 210nm, polydispersity index of 0.044, and zeta potential of -23.4mV. The electron microscopy images showed the nanometric size and spherical shape. The assay in soil showed that GML has a high toxicity while the GML nanocapsules showed decreased toxic effects. Nanostructuration also protected the Rhamdia quelen against the toxic effects of GML. Concluding, the formulation shows positive results and is useful to predict the success of development besides not damaging the soil.


Subject(s)
Anti-Infective Agents , Arthropods/growth & development , Fishes/growth & development , Laurates/toxicity , Monoglycerides/toxicity , Nanocapsules/toxicity , Soil Pollutants/toxicity , Water Pollutants, Chemical/toxicity , Animals , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/toxicity , Arthropods/drug effects , Ecotoxicology , Environmental Exposure
14.
Microb Pathog ; 97: 183-8, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27216238

ABSTRACT

The American Foulbrood Disease (AFB) is a fatal larval bee infection. The etiologic agent is the bacterium Paenibacillus larvae. The treatment involves incineration of all contaminated materials, leading to high losses. The Glycerol Monolaurate (GML) is a known antimicrobial potential compound, however its use is reduced due to its low solubility in water and high melting point. The nanoencapsulation of some drugs offers several advantages like improved stability and solubility in water. The present study aimed to evaluate the antimicrobial activity against P. larvae and the toxicity in bees of GML nanoparticles. The nanocapsules were produced and presented mean diameter of 210 nm, polydispersity index of 0.044, and zeta potential of -23.4 mV demonstrating the acceptable values to predict a stable system. The microdilution assay showed that it is necessary 142 and 285 µg/mL of GML nanocapsules to obtain a bacteriostatic and bactericidal effect respectively. The time-kill curve showed the controlled release of compound, exterminating the microorganism after 24 h. The GML nanocapsules were able to kill the spore form of Paenibacillus larvae while the GML do not cause any effect. The assay in bees showed that the GML has a high toxicity while the GML nanoparticles showed a decrease on toxic effects. Concluding, the formulation shows positive results in the action to combat AFB besides not causing damage to bees.


Subject(s)
Anti-Infective Agents/pharmacology , Anti-Infective Agents/toxicity , Bees/drug effects , Laurates/pharmacology , Laurates/toxicity , Monoglycerides/pharmacology , Monoglycerides/toxicity , Nanocapsules , Paenibacillus larvae/drug effects , Animals , Microbial Sensitivity Tests , Microbial Viability/drug effects , Paenibacillus larvae/growth & development , Paenibacillus larvae/physiology , Spores, Bacterial/drug effects , Spores, Bacterial/growth & development , Spores, Bacterial/physiology , Survival Analysis
15.
Microb Pathog ; 100: 170-178, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27544324

ABSTRACT

Infections due to microbial biofilm formation on the surface of catheters and other medical devices are constantly reported as a major cause of morbidity and mortality in patients admitted to hospitals. Furthermore, sessile cells are more resistant to phagocytosis and most antimicrobial, which complicates the treatment of such infections. Researches aimed at new antimicrobial originating mainly from plants have increased in recent years and the development of new strategies for their release is critical in combating the formation of biofilms. Geranium oil (GO) has proven antimicrobial activity. Because of this, the aim of this study was to develop nanoemulsions containing this oil (NEG) and evaluate its activity after the biofilm formation of Candida albicans, Candida tropicalis, Candida glabrata, and Candida krusei in hospital medical supplies. For quantification of the biofilm, crystal violet, total protein, and ATP-bioluminescence assays were used. The results revealed that GO and NEG showed lower MIC for C. albicans and C. tropicalis. The biofilms formed by different species of Candida on the surfaces of polyethylene and polyurethane were quantified. GO and NEG significantly inhibited the formation of biofilms in all species tested on the surfaces of polyethylene. However, NEG antibiofilm has had better activity than GO for C. albicans, C. tropicalis and C. glabrata, according to the surface potential analysis by atomic force microscopy (AFM). The analysis of the biofilm formation on the polyethylene surface by ATP-bioluminescence and CFU showed similar results. In both methods the formation of biofilm in the catheter occurred in greater quantity for C. albicans and C. tropicalis. GO did not significantly inhibit the formation of biofilms only in C. krusei, although NEG significantly increased this activity GO in all species tested when compared to the control training biofilm. The following study shows that the development of NEG may become an effective alternative to reduce the adhesion of microorganisms and prevent infections resulting from the use of some hospital medical materials.


Subject(s)
Antifungal Agents/pharmacology , Biofilms/drug effects , Candida/drug effects , Equipment and Supplies/microbiology , Pelargonium/chemistry , Plant Extracts/pharmacology , Antifungal Agents/isolation & purification , Candida/physiology , Emulsions/pharmacology , Hospitals , Microbial Sensitivity Tests , Plant Extracts/isolation & purification
16.
Environ Sci Pollut Res Int ; 30(8): 22024-22032, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36282387

ABSTRACT

The pandemic of COVID-19 (SARS-CoV-2 disease) has been causing unprecedented health and economic impacts, alerting the world to the importance of basic sanitation and existing social inequalities. The risk of the spread and appearance of new diseases highlights the need for the removal of these pathogens through efficient techniques and materials. This study aimed to develop a polyurethane (PU) biofoam filled with dregs waste (leftover from the pulp and paper industry) for removal SARS-CoV-2 from the water. The biofoam was prepared by the free expansion method with the incorporation of 5wt% of dregs as a filler. For the removal assays, the all materials and its isolated phases were incubated for 24 h with an inactivated SARS-CoV-2 viral suspension. Then, the RNA was extracted and the viral load was quantified using the quantitative reverse transcription (RT-qPCR) technique. The biofoam (polyurethane/dregs) reached a great removal percentage of 91.55%, whereas the isolated dregs waste was 99.03%, commercial activated carbon was 99.64%, commercial activated carbon/polyurethane was 99.30%, and neat PU foam reached was 99.96% for this same property and without statistical difference. Those new materials endowed with low cost and high removal efficiency of SARS-CoV-2 as alternatives to conventional adsorbents.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , Polyurethanes , Charcoal , Sensitivity and Specificity , RNA, Viral/genetics
17.
J Invertebr Pathol ; 109(3): 265-8, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22200645

ABSTRACT

The Gram-positive, spore-forming bacterium Paenibacillus larvae is the primary bacterial pathogen of honeybee brood and the causative agent of American foulbrood disease (AFB). One of the feasible alternative treatments being used for their control of this disease is essential oils. In this study in vitro antimicrobial activity of Andiroba and Copaíba essential oils against Paenibacillus species, including P. larvae was evaluated. Minimal inhibitory concentration (MIC) in Mueller-Hinton broth by the microdilution method was assessed. Andiroba registered MIC values of 1.56-25%, while the MICs values obtained for Copaíba oil were of 1.56-12.5%. In order to determine the time-response effect of essential oils on P. larvae, this microorganism was exposed to the oils for up to 48 h. After 24 h treatment with Andiroba oil and after 48 h treatment with Copaíba oil no viable cells of P. larvae ATCC 9545 were observed. The possible toxic effect of essential oils were assessed by the spraying application method of the same concentrations of MICs. Bee mortality was evident only in treatment with Andiroba oil and the Copaíba oil shows no toxic effects after 10 days of observation. Taking together ours results showed for the first time that these oils presented a high activity against Paenibacillus species showing that Copaíba oil may be a candidate for the treatment or prevention of AFB.


Subject(s)
Anti-Infective Agents/pharmacology , Bees/microbiology , Fabaceae/chemistry , Gram-Positive Bacterial Infections/drug therapy , Gram-Positive Bacterial Infections/veterinary , Oils, Volatile/pharmacology , Paenibacillus/drug effects , Animals , Microbial Sensitivity Tests
18.
Travel Med Infect Dis ; 49: 102390, 2022.
Article in English | MEDLINE | ID: mdl-35753659

ABSTRACT

BACKGROUND: SARS-CoV-2, the virus that causes COVID-19, is constantly mutating, leading to new variants that culminate in a temporal lineages fluctuation. B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated P.1 (VOC), P.2 (VOI) and other P.Xs proposed as new variants. METHODS AND RESULTS: In this study, through the Illumina platform, we performed the whole-genome sequencing of 26 positive samples of SARS-CoV-2. Employing variant calling analysis on FASTQ reads and phylogenetic inference, we report a brief dispersion of a potentially new B.1.1.28-derived variant detected between 2021 May and June in individuals crossing the border between Brazil and Argentina, and local spread to inpatients from hospitals at the Rio Grande do Sul state capital (Porto Alegre). Besides, the Rio Grande do Sul State SARS-CoV-2 genomic epidemiological data was analyzed and showed an important B.1.1.28 peak in RS at the same period (May-June), even in the presence of a major Gamma wave. CONCLUSIONS: The emergence of a putative B.1.1.28-derived lineage was identified in travelers crossing Brazil-Argentina border representing an important peak of B.1.1.28 in RS State with a decreased in Gamma variant frequency in the same period of time.


Subject(s)
COVID-19 , SARS-CoV-2 , Argentina/epidemiology , Brazil/epidemiology , COVID-19/epidemiology , Humans , Mutation , Phylogeny , SARS-CoV-2/genetics , Spike Glycoprotein, Coronavirus/genetics
19.
Braz J Microbiol ; 42(4): 1440-4, 2011 Oct.
Article in English | MEDLINE | ID: mdl-24031776

ABSTRACT

Genomic fragments of the HN and L genes from Brazilian bovine parainfluenza 3 virus (bPIV-3) isolated as contaminants from cell cultures and clinical specimens were amplified by reverse transcription-polymerase chain reaction (RT-PCR), sequenced using specific degenerate primers and analyzed by phylogenetic comparison with reference strains of bPI3V. The Brazilian isolates revealed a high degree of genomic when compared to SF4/32 prototype strain, within the recently proposed genotype A of bPIV-3.

20.
Biomed Pharmacother ; 133: 111052, 2021 Jan.
Article in English | MEDLINE | ID: mdl-33378958

ABSTRACT

The irrational use of medications has increased the incidence of microbial infections, which are a major threat to public health. Moreover, conventional therapeutic strategies are starting to become ineffective to treat these infections. Hence, there is a need to develop and characterize novel antimicrobial compounds. Phytochemicals are emerging as a safe and accessible alternative to conventional therapeutics for treating infectious diseases. Curcumin is extracted from the dried rhizome of the spice turmeric (Curcuma longa (Zingiberaceae)). However, the bioavailability of curcumin is low owing to its lipophilic property and thus has a low therapeutic efficacy in the host. A previous study synthesized structural variants of curcumin, which are called monocurcuminoids (CNs). CNs are synthesized based on the chemical structure of curcumin with only one methyl bridge. The biological activities of four previously synthesized CNs (CN59, CN63, CN67, and CN77), curcumin, and turmeric powder were examined in this study. Gas chromatography-tandem mass spectrometry analysis of curcumin and turmeric powder revealed similar peaks, which indicated the presence of curcumin in turmeric powder. The antioxidant activity of the test compounds was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) assays. The ABTS radical scavenging activities of the test compounds were similar to those of vitamin C. The minimum inhibitory concentration (MIC) values of the test compounds against seven microbial strains were in the range of 4.06-150 µg/mL. The MIC value was equal to minimum bactericidal concentration value for CN63 (150 µg/mL) and CN67 (120 µg/mL) against Staphylococcus aureus. The treatment combination of CN77 (8.75 or 4.37 µg/mL) and turmeric powder (9.37 or 4.68 µg/mL) exerted synergistic growth-inhibiting effects on Aeromonas hydrophila, Candida albicans, and Pseudomonas aeruginosa. Photodynamic therapy using 2X MIC of CN59 decreased the growth of Enterococcus faecalis by 4.18-fold compared to the control group and completely inhibited the growth of Escherichia coli. The results of the hemolytic assay revealed that the test compounds were not cytotoxic with half-maximal inhibitory concentration values ranging from 49.65-130.9 µM. The anticoagulant activity of most compounds was comparable to that of warfarin but higher than that of heparin. This indicated that these compounds target the intrinsic coagulation pathway. These results demonstrated that these CNs are a safe and promising alternative for curcumin.


Subject(s)
Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Bacteria/drug effects , Bioprospecting , Candida albicans/drug effects , Diarylheptanoids/pharmacology , Photochemotherapy , Photosensitizing Agents/pharmacology , Animals , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/toxicity , Antioxidants/chemical synthesis , Antioxidants/toxicity , Bacteria/growth & development , Benzothiazoles/chemistry , Biphenyl Compounds/chemistry , Blood Coagulation/drug effects , Candida albicans/growth & development , Diarylheptanoids/chemical synthesis , Diarylheptanoids/toxicity , Drug Resistance, Microbial , Hemolysis/drug effects , Microbial Sensitivity Tests , Photosensitizing Agents/chemical synthesis , Photosensitizing Agents/toxicity , Picrates/chemistry , Sheep, Domestic , Sulfonic Acids/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL